This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For Immediate Release: August 28, 2024 Washington, D.C. — In light of the Drug Enforcement Administration’s (DEA) announcement to schedule a hearing on the rescheduling of cannabis, Americans for Safe Access (ASA) emphasizes the urgent need for compassionate leadership in Congress to advocate for the rights of medical cannabis patients.
What's Inside For September 2024: DEA Hearing Delay on Cannabis Rescheduling Patients caught in the middle of CA Hemp Product Ban ASA releases What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety. Learn More about ASA Member Benefits & Join Today!
13 by the San Diego/Imperial Counties Joint Labor Management Cannabis Committee made up of representatives of UFCW Local 135 , and local companies March & Ash and Embarc. What’s more, synthesized Delta-9 THC is present in many of these products, despite being prohibited in both California’s cannabis and hemp programs.
For immediate release: Media Briefing on the Next Steps of the Rescheduling Process July 22, 2024, 1 pm ET Zoom Conference: Please go to the bottom of this page for the Zoom sign-in link.
Happy 2024 – let’s start the year off with a shout-out to Colorado, where the retail market is celebrating an anniversary. There’s an update on Alabama’s medical cannabis licensing program (meet the new year; same as the old year). The DEA is conducting a review of cannabis scheduling. million in taxes and fees.
However, many of them are still psychoactive, albeit at lower levels than traditional cannabis sold in legal states. A new delta-8 study has revealed that people in states without access to legal cannabis products are far more likely to seek out and consume delta-8 and delta-9 variants, whether it be flower, edibles, or tinctures.
states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Idaho Idaho is one of the staunchest anti-cannabis states.
Senate Democrats would like to see less re-scheduling and more de-scheduling of cannabis. Americans support cannabis legalization. VIRGINIA As we’ve discussed before , Virginia legalized cannabis, but has not yet set up a retail market. Now, some Senate Democrats are advocating that the DEA de-schedule cannabis altogether.
Cannabis Catalysts write by way of an introduction. “After taking the first steps towards the liberalization of hemp cultivation over the course of the last few years, at the end of 2018 Thailand’s government decided to legalize medical cannabis as the first Southeast Asian country. CC INSIGHTS THAILAND MEDICAL CANNABIS.
The Virginia Senate and the House of Delegates agreed on a compromise bill to legalize cannabis for use by adults and to regulate marijuana production and sales on February 27. As recent as 2016, the DEA has reviewed and determined that under its judgment marijuana should remain a Schedule I substance.”. Bill To Go Into Effect In 2024.
The Department of Health and Human Services released documents related to rescheduling cannabis. The DEA sends a letter to Georgia pharmacies. And finally, if you’re planning a wedding, you have a cannabis option. Well, apparently the Drug Enforcement Administration (DEA) noted that as well, and they didn’t take kindly to it.
attorneys about cannabis re-scheduling. We note that New York’s cannabis licensing program is facing yet another lawsuit. UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. Look for more on this in 2024 also.
The cannabis industry has been on a progressive incline for the last few years and 2021 is no exception. In fact, this year looks set to be one of the most successful years for cannabis reform in the United States so far. . At some point next year, New York will kick-start its recreational cannabis market.
The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Turns out, they were trying to get into cannabis in Florida as well. Cannabis research was also a big topic. See you next week!
one of just seven federally DEA- licensed cannabinoid research labs, had some encouraging news about how cannabinoids and cannaflavins can lengthen life spans while improving health spans. Punja sounded the alarm on the Hop Latent Viroid plague decimating the crops of western grower, calling it the “Covid of Cannabis.”
Cannabis-related permits and lab certifications Permits are a critical part of any cannabis business, but there are some that are unique to cannabis testing labs. First, since cannabis legalization is a state-level phenomenon, any cannabis lab needs a state license.
Welcome back to The Year In Weed, The Blunt Truth’s annual roundup of cannabis-related stories. Last year , I predicted there would be no federal cannabis legalization, but that perhaps states would legalize. Virgin Islands legalized adult-use cannabis. March brought an election defeat for adult-use cannabis.
Though, Oregon is actively in the process of establishing a model for psilocybin that would be like the state’s current medical cannabis system. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. View source.].
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA).
Today is another historic day in the history of cannabis control and regulation. In a much anticipated announcement, the Drug Enforcement Administration (DEA) issued a notice of proposed rulemaking to reschedule marijuana, from Controlled Substances Act (CSA) schedule I to schedule III (the “Proposed Rule”). 11, 2024) (“OLC Op.”).1
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. Notably, Europe saw significant movement in cannabis policy. As the U.S.
They’re calling it the Rural Prosperity and Food Security Act of 2024 (the “Senate bill”). The Senate bill follows on the House’s proposal, called the Farm, Food and National Security Act of 2024 (the “House bill”), offered in May. That could happen in 2024, but seems more likely in 2025 when the new Congress convenes.
” As of a few days ago, DEA reiterated this position in response to an inquiry by attorney Shane Pennington, even going so far as to note “cannabis-derived THCA does not meet the definition of hemp under the [Controlled Substances Act] because upon conversion for identification purposes as required by Congress, it is equivalent to [THC].”
Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.
Ability to source marijuana genetic material from outside Colorado Senate Bill 23-271 , which went into effect in early 2024, aims to enhance Colorados marijuana industry. Genetic material is defined as material used to propagate cannabis plants, including: Immature plants and small plant fragments with 0.3%
This week, we note that HHS released the full text of its report on cannabis rescheduling. DC is cracking down on cannabis “gifting” stores. HHS bases its recommendation on marijuana’s accepted medical use, and notes that cannabis has less potential for abuse than other drugs in Schedule I or II. Stay tuned!
Florida Ag Commissioner blasts Biden administration for arguing in lawsuit that medical cannabis patients “are too dangerous to trust” to possess firearms: [link]. Virginia 2024 adult use program may be postponed: [link]. Massachusetts has new cannabis law: [link]. Columbia considering legalizing cannabis: [link].
According to the Pew Research Center (2024), 88% of Americans believe cannabis should be legal for either medical or recreational use. If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision.
Schedule III substances are subject to certain controls not applicable to all other prescription drugs, including the requirement that a medical professional with a specific license issued by the Drug Enforcement Agency (DEA) must conduct an in-person examination before prescribing it. 1 Related Stories What’s the deal with ketamine?
Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.
Diamondback Investment Group, LLC , handed the DEA a big loss when it comes to hemp – at least for now. In Anderson , the court held that DEA’s interpretation that a host of hemp-derived products were illegal was essentially wrong. Raimondo , a 2024 US Supreme Court decision. delta-9 THC.
In no particular order, I’ll address a few reasons why the back half of 2024 will be a bad stretch for intoxicating hemp products. Raimondo , a 2024 US Supreme Court decision. Ever since Loper was decided, there have been a million different theories on how it could affect the cannabis and hemp industries.
Yesterday, the Drug Enforcement Administration (DEA) near-noticed a hearing for its marijuana rescheduling proposal. The hearing would begin on December 2, 2024 at 9 a.m. Back in March, when DEA agreed to initiate rulemaking to reschedule marijuana, I wrote that “I doubt cannabis will be on Schedule III by November.”
Historical evidence suggests that humans worldwide have been cultivating and consuming cannabis for tens of thousands of years, but cannabis use has skyrocketed in recent years, especially in the US. Our ancestors consumed cannabis flower for recreational, medicinal, and spiritual purposes.
The 91-year-old singer and songwriter has been a cannabis advocate since the 1950s, making himself one of the longest-running supporters of the plant in the world. This year, he’s been an active supporter of Kamala Harris during the upcoming election campaign, with much of his championing centering around cannabis.
Most Americans favor federal cannabis legalization. Nearly all Americans support medical cannabis legalization. Federal cannabis legislation isn’t going to happen Back in 2018, when California opened up for recreational cannabis licensing, all I heard was how federal cannabis legalization was around the corner.
As the cannabis industry awaits potential marijuana rescheduling, eyes seem focused on state-legal operators and the tax relief they might enjoy. But there’s a group of players who’ve been surprisingly quiet, despite potentially having the most to gain: DEA-registered bulk marijuana manufacturers. billion by 2027.
Cannabis and business immigration don’t mix. That’s not because a particular investment may not be sound, rather because federal law creates inherent conflicts between immigration eligibility and participating in a cannabis venture. Cannabis and immigration U.S. The INA is federal law and administered by the U.S.
Department of Health and Human Services (HHS) proposed reclassifying cannabis , a move that would shift cannabis from Schedule I to Schedule III. In a nutshell, it’s moving cannabis from Schedule I to Schedule III legal status. They must work closely with the Drug Enforcement Administration (DEA) to pass the move.
In each presidential election cycle, the Canna Law Blog runs a classy series of posts grading the candidates as to their positions on cannabis. Biden was the only viable Democratic candidate who opposed cannabis legalization in 2020. Biden’s positions on cannabis today Things have changed a bit in the past quadrennium.
In May 2024, the U.S. Department of Justice (DOJ) put forth a proposal to reclassify “marijuana” (the legal term for cannabis plants and their products with over 0.3% government’s stance on cannabis prohibition. What Would Rescheduling Mean for Cannabis in the U.S.?
Marijuana rescheduling is mired in an administrative rulemaking process, whereby the Drug Enforcement Administration (DEA) is the hapless, cynical proponent of a proposed Department of Justice (DOJ) rule. Midway through the rulemaking process, DEA Chief Administrative Law Judge John J. Lets call them the Villagers.) More on that below.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content